TY - JOUR
T1 - Clinical outcomes of endoscopic submucosal dissection for esophageal squamous cell carcinoma with esophageal varices
T2 - Multicenter retrospective study
AU - Tohoku GI Endoscopy Group
AU - Toya, Yosuke
AU - Hatta, Waku
AU - Shimada, Tomohiro
AU - Matsuhashi, Tamotsu
AU - Shiroki, Takeharu
AU - Sasaki, Yu
AU - Tatsuta, Tetsuya
AU - Nakamura, Jun
AU - Hanabata, Norihiro
AU - Horikawa, Yohei
AU - Nagino, Ko
AU - Koike, Tomoyuki
AU - Masamune, Atsushi
AU - Harada, Yoshihiro
AU - Ohira, Tetsuya
AU - Iijima, Katsunori
AU - Abe, Yasuhiko
AU - Hikichi, Takuto
AU - Igarashi, Shohei
AU - Fushimi, Saki
AU - Takeda, Hiroaki
AU - Fukuda, Shinsaku
AU - Matsumoto, Takayuki
AU - Akasaka, Risaburo
AU - Abe, Hiroko
AU - Mikami, Tatsuya
AU - Chinda, Daisuke
AU - Kikuchi, Hidezumi
AU - Kato, Tsunetaka
AU - Hashimoto, Minami
AU - Yanagita, Takumi
AU - Fujishima, Shoichiro
N1 - Publisher Copyright:
© 2023 Japan Gastroenterological Endoscopy Society.
PY - 2024/3
Y1 - 2024/3
N2 - Objectives: Clinical outcomes of endoscopic submucosal dissection (ESD) for esophageal squamous cell carcinoma (ESCC) with esophageal varices (EVs) are obscure. We aimed to elucidate the clinical outcomes of ESD for ESCC with EVs in a multicenter, retrospective study. Methods: We established a retrospective cohort of 30 patients with ESCC complicating EVs, who underwent ESD at 11 Japanese institutions. Rates of en bloc resection and R0 resection, procedure time, and adverse events were evaluated as indicators of the feasibility and safety of ESD. Additional treatment, recurrence, and metastasis of the lesions were evaluated as indicators of the long-term efficacy of ESD. Results: Portal hypertension was caused by cirrhosis, of which alcohol was the most common cause. En bloc resection was achieved in 93.3% and R0 resection in 80.0% of the patients. The median procedure time was 92 min. Adverse events included a case of uncontrolled intraoperative bleeding leading to discontinuation of ESD and a case of esophageal stricture due to extensive resection. During the follow-up period of a median for 42 months, a patient with local recurrence and another patient with liver metastasis were observed. One patient died of liver failure after receiving chemoradiotherapy as an additional treatment after ESD. No patient died of ESCC. Conclusion: This multicenter, retrospective cohort study demonstrated the safety and efficacy of ESD for ESCC with EVs. Further studies are needed to establish appropriate treatment methods for EVs before ESD and additional treatments for patients with insufficient ESD.
AB - Objectives: Clinical outcomes of endoscopic submucosal dissection (ESD) for esophageal squamous cell carcinoma (ESCC) with esophageal varices (EVs) are obscure. We aimed to elucidate the clinical outcomes of ESD for ESCC with EVs in a multicenter, retrospective study. Methods: We established a retrospective cohort of 30 patients with ESCC complicating EVs, who underwent ESD at 11 Japanese institutions. Rates of en bloc resection and R0 resection, procedure time, and adverse events were evaluated as indicators of the feasibility and safety of ESD. Additional treatment, recurrence, and metastasis of the lesions were evaluated as indicators of the long-term efficacy of ESD. Results: Portal hypertension was caused by cirrhosis, of which alcohol was the most common cause. En bloc resection was achieved in 93.3% and R0 resection in 80.0% of the patients. The median procedure time was 92 min. Adverse events included a case of uncontrolled intraoperative bleeding leading to discontinuation of ESD and a case of esophageal stricture due to extensive resection. During the follow-up period of a median for 42 months, a patient with local recurrence and another patient with liver metastasis were observed. One patient died of liver failure after receiving chemoradiotherapy as an additional treatment after ESD. No patient died of ESCC. Conclusion: This multicenter, retrospective cohort study demonstrated the safety and efficacy of ESD for ESCC with EVs. Further studies are needed to establish appropriate treatment methods for EVs before ESD and additional treatments for patients with insufficient ESD.
KW - endoscopic submucosal dissection
KW - esophageal squamous cell carcinoma
KW - esophageal varices
KW - liver cirrhosis
UR - http://www.scopus.com/inward/record.url?scp=85165083863&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85165083863&partnerID=8YFLogxK
U2 - 10.1111/den.14619
DO - 10.1111/den.14619
M3 - Article
C2 - 37343173
AN - SCOPUS:85165083863
SN - 0915-5635
VL - 36
SP - 314
EP - 322
JO - Digestive Endoscopy
JF - Digestive Endoscopy
IS - 3
ER -